Patients with CML-CP without BCR::ABL1T315I with multiple prior TKIs demonstrated reliable and durable MRs while using asciminib, with favorable safety and tolerability. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.